- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00725153
Evaluation of Deposits on Contact Lenses Worn Daily Wear
July 20, 2012 updated by: Alcon Research
The purpose of this study was to measure front surface deposits on contact lenses when worn for ten hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or older.
- Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses.
- Successfully wearing hydrogel or silicone hydrogel contact lenses prior to enrollment in the study.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Evidence or history of keratitis (dendritic keratitis); viral disease of the cornea and/or conjunctiva; acute bacterial disease of the cornea and/or conjunctiva and/or eyelids; infection of the eye; and/or fungal disease of the eye.
- One functional eye or a monofit lens.
- Ocular conditions such as active acute blepharitis, conjunctival infections, and iritis.
- Any slit-lamp finding score of (1) at the Screening Visit as defined in protocol.
- Use of concomitant topical ocular prescription or over-the-counter (OTC) ocular medications.
- History of seasonal allergies with significant ocular side effects which may have an adverse impact on contact lens wear.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: PureVision/Acuvue 2
PureVision contact lenses worn first, with Acuvue 2 contact lenses worn second.
Both products worn for 10 hours each.
|
Commercially marketed, soft contact lenses worn bilaterally for 10 hours
Other Names:
Commercially marketed, soft contact lenses worn bilaterally for 10 hours
Other Names:
|
|
Other: Acuvue 2/PureVision
Acuvue 2 contact lenses worn first, with PureVision contact lenses worn second.
Both products worn for 10 hours each.
|
Commercially marketed, soft contact lenses worn bilaterally for 10 hours
Other Names:
Commercially marketed, soft contact lenses worn bilaterally for 10 hours
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Front Surface Lens Deposits
Time Frame: 10 hours
|
Film and discrete deposits were assessed with a slit-lamp after 10 hours of lens wear.
Film deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=slight, deposition occupying 1-5% of lens front surface; 2=mild, deposition occupying 6-15% of lens front surface; 3=moderate, deposition occupying 16-25% of lens front surface; 4=severe, deposition occupying >25% of lens front surface.
Discrete deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=microdeposits (less than or equal to 10 dots); 2=microdeposits (greater than 10 dots); 3=macro deposits; 4=one or more jelly bumps.
Participants were classified into Front Surface Lens Deposits <2 (less than grade 2 for both film and discrete) and into front surface lens deposits >1 (greater than grade 1 for either film, discrete, or both).
|
10 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
September 1, 2008
Study Registration Dates
First Submitted
July 28, 2008
First Submitted That Met QC Criteria
July 29, 2008
First Posted (Estimate)
July 30, 2008
Study Record Updates
Last Update Posted (Estimate)
August 23, 2012
Last Update Submitted That Met QC Criteria
July 20, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MS-006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Myoptechs, IncUniversity of Waterloo School of Optometry and Vision ScienceNot yet recruitingMyopia: Refractive Error
-
Perfect Lens, LLCCompletedRefractive Error CorrectionPanama
-
Essilor InternationalRecruitingRefractive Error | AmetropiaUnited States
Clinical Trials on Balafilcon A contact lenses (PureVision)
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedCorneal Edema | Bullous Keratopathy | Corneal Dystrophy | Entropion | Corneal ErosionUnited States
-
Alcon ResearchCompleted
-
Bausch & Lomb IncorporatedCompleted
-
University of WaterlooAlcon ResearchCompleted
-
Bausch & Lomb IncorporatedCompletedVision DisordersUnited States
-
ORA, Inc.WithdrawnContact Lens ComplicationUnited States
-
Alcon ResearchCompletedRefractive Error | Astigmatism | MyopiaUnited States
-
CIBA VISIONUniversity of WaterlooCompleted